相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
Jiajia Zhang et al.
CLINICAL CANCER RESEARCH (2020)
Immune checkpoint inhibitors: a promising anticancer therapy
Sima Singh et al.
DRUG DISCOVERY TODAY (2020)
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer
Jiefei Han et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?
Patrick Schummer et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Jackson G. Egen et al.
IMMUNITY (2020)
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto et al.
TRANSLATIONAL ONCOLOGY (2020)
TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer
Timothy John Looney et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Using T Cell Receptor Repertoires to Understand the Principles of Adaptive Immune Recognition
Philip Bradley et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost et al.
NATURE MEDICINE (2019)
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review
Luca Mazzarella et al.
EUROPEAN JOURNAL OF CANCER (2019)
PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition
Yilun Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients
Arjun Khunger et al.
ONCOIMMUNOLOGY (2019)
Characterization of Distinct T Cell Receptor Repertoires in Tumor and Distant Non-tumor Tissues from Lung Cancer Patients
Xiang Wang et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2019)
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER RESEARCH (2019)
Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma
Erik Yusko et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma
Sabrina A. Hogan et al.
CANCER IMMUNOLOGY RESEARCH (2019)
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis
John-William Sidhom et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
P. M. Forde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
Ludmila Danilova et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Immune Repertoire Sequencing Using Molecular Identifiers Enables Accurate Clonality Discovery and Clone Size Quantification
Ke-Yue Ma et al.
FRONTIERS IN IMMUNOLOGY (2018)
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
Alexander C. Hopkins et al.
JCI INSIGHT (2018)
Quantifiable predictive features define epitope-specific T cell receptor repertoires
Pradyot Dash et al.
NATURE (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Identifying specificity groups in the T cell receptor repertoire
Jacob Glanville et al.
NATURE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
Jie Bai et al.
ONCOTARGET (2017)
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder et al.
PLOS MEDICINE (2017)
Quantitative Characterization of the T Cell Receptor Repertoire of Naive and Memory subsets Using an Integrated experimental and Computational Pipeline Which Is Robust, economical, and Versatile
Theres Oakes et al.
FRONTIERS IN IMMUNOLOGY (2017)
Overview of methodologies for T-cell receptor repertoire analysis
Elisa Rosati et al.
BMC BIOTECHNOLOGY (2017)
RTCR: a pipeline for complete and accurate recovery of T cell repertoires from high throughput sequencing data
Bram Gerritsen et al.
BIOINFORMATICS (2016)
TRIg: a robust alignment pipeline for non-regular T-cell receptor and immunoglobulin sequences
Sheng-Jou Hung et al.
BMC BIOINFORMATICS (2016)
The role of neoantigens in response to immune checkpoint blockade
Nadeem Riaz et al.
INTERNATIONAL IMMUNOLOGY (2016)
How many TCR clonotypes does a body maintain?
Grant Lythe et al.
JOURNAL OF THEORETICAL BIOLOGY (2016)
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients
S. Mimmi et al.
LEUKEMIA (2016)
Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire
Jennifer S. Sims et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
Sumit K. Subudhi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V. Masucci et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
IMSEQ-a fast and error aware approach to immunogenetic sequence analysis
Leon Kuchenbecker et al.
BIOINFORMATICS (2015)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
MiXCR: software for comprehensive adaptive immunity profiling
Dmitriy A. Bolotin et al.
NATURE METHODS (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Bioinformatic and Statistical Analysis of Adaptive Immune Repertoires
Victor Greiff et al.
TRENDS IN IMMUNOLOGY (2015)
VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires
Mikhail Shugay et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4(+) T cell receptor repertoire clonality
Wei Zhu et al.
ONCOIMMUNOLOGY (2015)
Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
Michael A. Postow et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Nivolumab for the treatment of cancer
Anasuya Gunturi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencinge
Mathieu Giraud et al.
BMC GENOMICS (2014)
Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice
Victor Greiff et al.
BMC IMMUNOLOGY (2014)
Deconstructing the Peptide-MHC Specificity of T Cell Recognition
Michael E. Birnbaum et al.
CELL (2014)
The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade
Antoni Ribas et al.
CLINICAL CANCER RESEARCH (2014)
CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
Lidia Robert et al.
CLINICAL CANCER RESEARCH (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
Charles G. Drake et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
Edward Cha et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Quantification of HTLV-1 Clonality and TCR Diversity
Daniel J. Laydon et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
High Frequency of Herpesvirus-Specific Clonotypes in the Human T Cell Repertoire Can Remain Stable over Decades with Minimal Turnover
M. A. Neller et al.
JOURNAL OF VIROLOGY (2013)
Subtle changes in TCRα CDR1 profoundly increase the sensitivity of CD4 T cells
Jennifer N. Lynch et al.
MOLECULAR IMMUNOLOGY (2013)
MiTCR: software for T-cell receptor sequencing data analysis
Dmitriy A. Bolotin et al.
NATURE METHODS (2013)
Ecological analysis of antigen-specific CTL repertoires defines the relationship between naive and immune T-cell populations
Paul G. Thomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Using synthetic templates to design an unbiased multiplex PCR assay
Christopher S. Carlson et al.
NATURE COMMUNICATIONS (2013)
Sequence analysis of T-cell repertoires in health and disease
Daniel J. Woodsworth et al.
GENOME MEDICINE (2013)
Next generation sequencing for TCR repertoire profiling: Platform-specific features and correction algorithms
Dmitry A. Bolotin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Counting absolute numbers of molecules using unique molecular identifiers
Teemu Kivioja et al.
NATURE METHODS (2012)
Why must T cells be cross-reactive?
Andrew K. Sewell
NATURE REVIEWS IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes
Rene L. Warren et al.
GENOME RESEARCH (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
On the Composition of the Preimmune Repertoire of T Cells Specific for Peptide-Major Histocompatibility Complex Ligands
Marc K. Jenkins et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
Harlan S. Robins et al.
BLOOD (2009)
Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing
J. Douglas Freeman et al.
GENOME RESEARCH (2009)
Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing
Scott D. Boyd et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Structural determinants of T-cell receptor bias in immunity
Stephen J. Turner et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
IMGT/LIGM-DB, the IMGT (R) comprehensive database of immunoglobulin and T cell receptor nucleotide sequences
Veronique Giudicelli et al.
NUCLEIC ACIDS RESEARCH (2006)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Diversity in the CDR3 region of VH is sufficient for most antibody specificities
JL Xu et al.
IMMUNITY (2000)
分享论文
